- Vivus filed for bankruptcy in Delaware and listed as much as $500m of assets and liabilities each in its petition
- IEH Biopharma is a subsidiary of Icahn Enterprises
- Vivus wants to have the reorganization plan confirmed by court on August 17, per statement
- Co. will continue its clinical and commercial operations, including the sales and marketing of weight management medication and other drugs, ...
July 7, 2020, 9:41 PM